Ascites Market – Industry Trends and Forecast to 2029

The Ascites Market size was valued at USD 2.50 Bn in 2022 and is expected to reach USD 3.34 Bn by 2029, at a CAGR of 4.2%
Ascites Market:
Ascites is a medical condition that occurs when there is an abnormal accumulation of fluid in the abdominal cavity, it is commonly associated with liver cirrhosis, but can also occur due to other conditions, such as kidney disease, cancer, and heart failure. Liver cirrhosis contributes around 10% to the prevalence of ascites. Also, around 75% of patients who present with ascites have underlying cirrhosis, with the remainder being due to malignancy 10%, heart failure 3%, tuberculosis 2%, pancreatitis 1%, and other rare causes. The ascites market encompasses different types of diagnostic and treatment options available to conclude the full scope of the market.

Key Benefits of Ascites Market Report:

1.The Ascites Report is a comprehensive analysis that includes various factors including market drivers, restraints, opportunities, regional analysis, and competitive landscape. Those factors play a crucial impact on growth during the forecast period.

2.The report is carved using analytical tools such as SWOT analysis, Porter’s Five Forces analysis, and PESTEL analysis used to conduct the market analysis. This report provides a 360-degree aspect of the market.

3.The report furthermore, provides an overview of the Production and Supply chain, retailers, and Demand and Consumption, which is necessary to understand the regional market.

4.The Ascites market includes producers, refiners, traders, and end-users, who play a crucial role in shaping the market dynamics.

5.Primary research involves gathering data through primary sources such as interviews with industry experts, company representatives, and end-users to gain insights into the market dynamics, demand, and supply patterns, and emerging trends.

6.Secondary Research involves gathering data from secondary sources such as reports, company websites, industry journals, and government publications to estimate market size and market shares.

7.Ascites market report consists of quantitative Analysis such as analyzing numerical data such as production volumes, market size, and growth rates to identify patterns and trends. And qualitative analysis involves non-numerical data such as consumer preferences, market perception, and industry trends to gain insights into the market.To know about the Research Methodology :- Request Free Sample Report

Drivers:

1.The increasing prevalence of liver cirrhosis is the primary cause of the ascites. Which is a global health concern and a major driver for the ascites market. According to the study, liver cirrhosis is responsible for 1.3% of all deaths worldwide, with over 1 million deaths per year.

2.The advancement of diagnostic imaging techniques, such as ultrasound, MRI, or CT scan, has made the early detection of ascites and its underlying cause possible with increased accuracy and in less time. The development of contrast-enhanced ultrasound (CEUS) has significantly improved the diagnostic accuracy of ascites as it helps providers see the flow of blood through your organs and blood vessels.

3.The increasing prevalence of age-related medical conditions such as liver cirrhosis, which rotationally leads to ascites in the elderly population, increases the risk of developing ascites in the elderly. This is expected to drive market growth. Globally, the number of people aged 65 and older is expected to triple by 2050, from 703 million in 2019 to 1.5 billion
Distribution of Population aged 65 years or over by region, 2019 and 2050(%)


Restraints:

1.Treatment for ascites can be expensive, depending on its underlying cause and severity. This could be a significant barrier for patients who may not have access to adequate health insurance coverage or financial resources.

2.The treatment of ascites requires specialized facilities and healthcare professionals who have experience in managing the conditions. This is expected to be a significant restrain for the growth of the market.

Challenges:

Lack of Awareness of Ascites is a relatively unknown medical condition and many times diagnosed when the condition has progressed to an advanced stage. This delayed diagnosis and treatment leads to poor treatment outcomes. A study found that only 44% of patients with liver cirrhosis and ascites were aware of their condition.

The risk of complications of ascites leads to several complications such as infection, kidney failure, and peritonitis. This treatment needs careful monitoring and treatment to prevent complications. The rate of peritonitis while treatment of ascites is about 30%. This is the major challenge for the market players which is expected to hinder market growth.

Opportunities:

Development of new and effective treatments which required less time of treatment, such as Immunomodulatory therapies could significantly improve the results of treatment.

Increasing Investment in Healthcare infrastructure in developing countries is expected to boost opportunities in the regional market and provide more options in specialized healthcare facilities. The Indian government's Ayushman Bharat scheme, which aims to provide universal healthcare coverage to the population, will cover poor and vulnerable families (Approx. 50 cr. Beneficiaries) providing coverage up to 5 lakh rupees per family per year.
Ascites Market Segmentation:
The Ascites Market is segmented into Diagnosis, Treatment, and End-User.The ascites market can be divided into segments based on diagnosis, treatment, and end-user.

Segmentation by Diagnosis:

Imaging Tests include technologies like ultrasound, CT scan, or MRI, which are imaging tests used to diagnose ascites. These tests are used to identify the cause and presence of fluid in the abdomen. Imaging tests also help to determine the size of the fluid collection and assess the condition and also provide vital information about drainage or other treatments.

Blood tests used technics such as enzymes, electrolytes, and other chemicals which can measure using blood tests to identify the underlying causes of ascitic.

The paracentesis procedure includes the removal of a sample through a needle inserted into the abdomen to analyze the root cause of ascites.

The advancement in imaging technology is expected to dominate the segment within the forecast period

Segmentation by Treatment:

Dietary alterations involve mainly restricting sodium consumption to mitigate fluid retention.

Medications such as diuretics can help reduce the amount of fluid in the cavity and result in better outcomes.

Therapeutic Paracentesis in this type of therapeutic way is used to remove a significant amount of ascitic fluid to relieve symptoms and mitigate the risk of complications.

Shunt placement A shunt is inserted in some cases to drain excess fluid from the abdomen into the bloodstream.

A liver transplant is done in severe cases of ascites caused by liver cirrhosis.

The Ascites Market report includes other remaining segment analyses with detailed explanations and examples. The report covers the regional, End-user, and Type segments and their impact on the market.
Ascites Market Regional Analysis:
The Ascites Market can be analyzed regional, with major regions including North America, Europe, Asia-Pacific, and the Rest of the World. Each region has unique trends and important Ascites.

North America is expected to dominate the ascites market within the forecast period due to the high prevalence of liver cirrhosis, which is a primary reason to boost the regional market. According to the study, approximately 30,000 people in the US die each year due to liver disease. The presence of market key players and the availability of advanced healthcare infrastructure and high spending in the healthcare field contribute to the dominance of the market. Mortality from cirrhosis has increased from 6 per 100 000 population in 1993 to 12.7 per 100 000 population in 2000.Europe is the second-largest market for ascites market due to the high prevalence of liver cirrhosis and other major medical conditions. A study shows approximately 150,000 people in Europe die each year due to liver disease. Also, the market is expected to boost with the availability of advanced healthcare facilities.

The Asia-Pacific is expected to show to grow with the fastest CAGR than North America and Europe due to the high prevalence of liver cirrhosis and the growing investment in healthcare. Incrising awareness about liver disease and funding is expected to increase the market within the forecast period.

The Ascites Market report includes with remaining major regions which expected to contribute to the growth of the market. Also, an in-depth analysis of all regions with the appropriate graphics and illustrations is available in the report.
Ascites Market Competitive Landscape:
The Ascites Market is highly competitive, with several key players operating in the market. The Ascites Market is highly concentrated, with a few major players dominating the industry.

1.The competitive landscape of the ascites market is highly fragmented, with a large number of companies working and competing for market share. The market is dominated by some key players such as Pfizer, Inc., Novartis International AG, Sanofi S.A., and Merck & Co., Inc.

2.Key players in the market players are focusing on strategies to maintain and improve their market position. The most important strategies include mergers and acquisitions, collaborations, and partnerships. For Example, Sanofi S.A. completed the acquisition of Kymab Limited which is a clinical-stage biopharmaceutical company.

3.In 2019 Novartis AG announced the launch of a new drug called Adakveo, which helps to reduce pain and reduce the risk of developing vaso-occlusive crises.

Overall, the Ascites Market is expected to remain highly competitive in the coming years, with companies focusing on developing advanced technologies that can provide better treatment and output.

The Ascites Market report of MMR includes profiles for market players with their mergers and acquisition which provide in-depth knowledge of the market and help in decision making. With the advent of new and advanced technologies, and heavy investment in R&D has significantly improved, and the market is expected to witness steady growth in the forecast years.
Global Ascites Market Scope: Inquire before buying



Global Ascites Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 2.50 Bn.


Forecast Period 2023 to 2029 CAGR:
4.2%
Market Size in 2029:
US $ 3.34 Bn.


 Segments Covered:
by Type
Transudative
Exudative
Others


by Diagnosis
Imaging Tests
Blood Tests
Paracentesis


by Treatment
sodium reduction
Medications
Therapeutic Paracentesis
Shunt Placement
Liver Transplant


by End-User
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers



Ascites Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Ascites Market key players:
1. Pfizer, Inc.
2. Novartis International AG
3. Sanofi S.A.
4. Merck & Co.,Inc.
5. BioVie inc.
6. Fresenius SE & Co. KGaA
7. F. Hoffmann-La Roche Ltd.
8. AstraZeneca
9. Teva Pharmaceutical Industries Ltd.
10. GSK plc.
11. WOCKHARDT

Frequently Asked Questions:
1.What is Ascites?
A: Ascites is a medical condition that occurs when there is an abnormal accumulation of fluid in the abdominal cavity, it is commonly associated with liver cirrhosis, but can also occur due to other conditions, such as kidney disease, cancer, and heart failure.

2. What are some of the factors driving growth in the Ascites market?
A: The increasing prevalence of liver cirrhosis, the advancement of diagnostic imaging techniques, and the increasing prevalence of age-related medical conditions are some of the drivers for the Ascites market.

3. What are some of the key players in the Ascites market?
A: Some of the leading companies operating in the Ascites Marker are Pfizer, Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., BioVie Inc., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche Ltd., AstraZeneca, Teva Pharmaceutical Industries Ltd., GSK plc., WOCKHARDT, etc.

4. What are some of the major challenges facing the Ascites market?
A: Lack of Awareness of Ascites as it is a relatively unknown medical condition and the risk of complications of ascites are the major challenges for the Ascites market.

5. What are some of the emerging trends in the Ascites Market?
A: Development of new and effective treatments which is time efficient is an emerging trend in the Ascites Market.